Prognosis of Thyroid Cancer Related to Pregnancy : A Systematic Review

Abstract EN

Differentiated thyroid cancer (DTC) is the second most common cancer in pregnancy.

Its management is a challenge for both doctors and patients, and the best timing for surgery is unclear.

A systematic review evaluating the prognosis of DTC in pregnant patients was conducted.

After reviewing 401 unique citations and 54 full texts, 4 studies that compared the prognosis of patients with DTC related to pregnancy (DTC diagnosed during pregnancy or within 12 months after childbirth) or not were included.

In two studies the primary outcome was overall survival, in one study the primary outcomes were recurrent disease and death related to thyroid cancer, and in one study the primary outcome was recurrent or persistent disease.

In the first two studies, there was no difference in overall survival in patients with pregnancy-related DTC, when compared with matched controls; in one study, there was no difference in death caused by DTC nor recurrence in DTC related to pregnancy.

Nevertheless, in a recent retrospective study, a higher rate of recurrent or persistent DTC was observed in patients with DTC related to pregnancy.

There are not many studies on which to base treatment decisions in pregnant patients with DTC.